• ¿Los Formularios Nacionales (Cuadros Básicos) Provocan Oligopolios E Incentivan a Tener Precios Altos?

    Nov 1, 2013, 00:00

  • Differential Diagnosis of Leg Ulcers – Medical and Health Economics Aspects

    Nov 1, 2013, 00:00

  • Health Care Resources Utilization and Associated Costs in Patients with COPD with or without Asthma- A Retrospective, Population-Based Observational Study

    Nov 1, 2013, 00:00

  • ISPOR 4th Latin America Conference Author Index

    Nov 1, 2013, 00:00

  • Prevelance of Hydeted Disease in Sugicaly Operated Patient in Some Libyan General Hospital

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De La Perfusión Aislada De Extremidad Con Tasonermia En Pacientes Con Sarcoma De Tejido Blando Irresecable

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of the United States Veteran Patients Diagnosed with Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?

    Nov 1, 2013, 00:00

  • Evaluation of Variable Relevance and Accessibility to Support Personalized Medicine in Breast Cancer

    Nov 1, 2013, 00:00

  • Evaluación Costo-Efectividad Y De Valor Social De Un Programa De Intervención En Población Infantil En Situación De Vulnerabilidad, Rezago O Déficit En El Desarrollo Integral - Chile 2012

    Nov 1, 2013, 00:00

  • Cross-Markets Variability of Innovation Benefit’s Evaluations. How Italy Compares to France, Germany and the United States

    Nov 1, 2013, 00:00

  • Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients- Significant Increase of Transportation Needs and Home Visits

    Nov 1, 2013, 00:00

  • An Economic Evaluation of the Triple HCV Treatment Regimen for G1 Naïve Patients in the Greek Health Care System

    Nov 1, 2013, 00:00

  • Novel Market Access Models for Cancer Drugs

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life of Patients on Opiate Replacement Therapy

    Nov 1, 2013, 00:00

  • Effect of Smoking Status on Health Care Costs and Resource Utilization in Patients with Chronic-Obstructive-Pulmonary-Disease in Clinical Practi A Retrospective Nested Case-Control Economic Study

    Nov 1, 2013, 00:00

  • Consumption of Biosimilar Drugs in Campania Region in the Years 2009-2012

    Nov 1, 2013, 00:00

  • Don’t Make Me Wait- The Variance Reduction Technique for Faster Monte Carlo Simulations in Cost Effectiveness Models on Web

    Nov 1, 2013, 00:00

  • Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden- A Follow-Up of 38,956 Patients in a Real Clinical Setting

    Nov 1, 2013, 00:00

  • The Impact of Public Formularies Guidelines on Community Acquired Pneumonia (CAP) Drugs in Mexico

    Nov 1, 2013, 00:00

  • Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids- A Systematic Review and Indirect Treatment Comparison

    Nov 1, 2013, 00:00

  • Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio

    Nov 1, 2013, 00:00

  • Results from a Two-Stage Delphi Process to Identify Cardiometabolic Risk Factors in Adrenal Insufficiency Patients and Understand Current Treatment in Italy

    Nov 1, 2013, 00:00

  • Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease

    Nov 1, 2013, 00:00

  • The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Are Public Subsidies Effective to Reduce Hospitalizations

    Nov 1, 2013, 00:00

  • Rationale for Initiating and Switching Biologic Therapy in Patients with Rheumatoid Arthritis- Results of a European Chart Review Study

    Nov 1, 2013, 00:00

  • Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto Económico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Evaluación De Costo-Efectividad De Certolizumab Pegol Comparado Con Etanercept En El Tratamiento De Artritis Reumatoidea En Colombia

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Public Health Care System in Brazil- Results from a Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • Evaluating the Economic Impact of Technological Advances in Diagnostics- The Case of High Throughput Sequencing for Hereditary Breast Cancer

    Nov 1, 2013, 00:00

  • Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing- Impact of Generic Prescribing on Cost

    Nov 1, 2013, 00:00

  • Chronic Patients’ Perceptions About Generic Medicines in Gree Findings from a Cross Sectional Survey

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective Surgery

    Nov 1, 2013, 00:00

  • Economic Burden of Inpatient Post-Admission Dehydration – Retrospective Database Analysis in Us

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

    Nov 1, 2013, 00:00

  • Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization Perspective

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Different Strategies to Treat Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Reduction in Fixation Time and Related Surgical Stress with the Use of Ethicon Securestrap™ Open Absorbable Strap Fixation Device in the Deployment of Intra-Peritoneal Onlay Mesh (IPOM) for Open Ventral Hernia Repair

    Nov 1, 2013, 00:00

  • Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization- National Estimates for Medicare Beneficiaries, 2002 to 2009

    Nov 1, 2013, 00:00

  • Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)

    Nov 1, 2013, 00:00

  • Effect of Antiviral Treatment Rates on the Predicted Future Burden of Genotype-1 Chronic Hepatitis C in the United Kingdom

    Nov 1, 2013, 00:00

  • Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study

    Nov 1, 2013, 00:00

  • The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis - Khoala Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

    Nov 1, 2013, 00:00

  • Self-Reported Health Status and EQ-5D-3L Values of the Argentine Population- Comparing 2005 Versus 2009 National Risk Factor Surveys

    Nov 1, 2013, 00:00

  • Stroke Prevention in Non-Valvular Atrial Fibrillation- Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Costo Efectividad Del Antibiótico Oral Vs. Local En Mujeres No Gestantes Con Flujo Vaginal Sugestivo De Vaginosis Bacteriana En Colombia

    Nov 1, 2013, 00:00

  • Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis

    Nov 1, 2013, 00:00

  • Analysis of Adverse Reactions of Medicine in Ukraine

    Nov 1, 2013, 00:00

  • Systematic Literature Reviews at the Heart of Health Technology Assessment- A Comparison Across Markets

    Nov 1, 2013, 00:00

  • An Analysis of the Cost Effectiveness of Left Atrial Appendage Closure for the Prevention of Stroke in Patients with Atrial Fibrillation and Absolute Contraindications to Warfarin Therapy

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

    Nov 1, 2013, 00:00

  • Correlating Cost Effectiveness Output with Patient Level Data Input Via the IMS Core Diabetes Model (CDM)

    Nov 1, 2013, 00:00

  • The Use of Dexa Scans in Postmenopausal Osteoporosis Is Associated with Reduced Long Term Fracture Risk

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Routine Infant Vaccination Strategies in Russia- An Economic Evaluation

    Nov 1, 2013, 00:00

  • Evaluation of the Length of Hospital Stay for Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Translation and Validation of Hindi Version of Diabetes Quality of Life – Measure (DQOL-M) in Indian Type 2 Diabetes Patients

    Nov 1, 2013, 00:00

  • Beyond Patent Expiry- Development of a Model for Pricing Generic Drugs in South Africa

    Nov 1, 2013, 00:00

  • Risk Factors Influencing the Viral Transmission and the Potential Development of HPV-Induced Pathologies

    Nov 1, 2013, 00:00

  • Acute Asthma Characteristics and Asthma Control in Latin America

    Nov 1, 2013, 00:00

  • Using a “Standards of Care Economic Model” to Quantify Barriers and Potential Solutions to Providing Optimal Guideline-Driven Care to Patients with Diabetes Mellitus in the United States

    Nov 1, 2013, 00:00

  • Relative Clinical and Economic Value of Ipilimumab in Mexico

    Nov 1, 2013, 00:00

  • Quality Assurance of Fourth Hurdle Concerning to Drugs and Medical Devices

    Nov 1, 2013, 00:00

  • Clinical and Cost-Effectiveness of Non-Pegylated Liposomal Doxorubicin for Non-Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2013, 00:00

  • Características Socioeconómicas De Pacientes Con Enfermedad Vascular Cerebral Y Antecedentes De Tabaquismo Tratados En Un Hospital De Tercer Nivel De México

    Nov 1, 2013, 00:00

  • Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis- Results of a European Chart Review Study

    Nov 1, 2013, 00:00

  • Estimating the Association Between the Oxford Hip Score (OHS) and EQ-5D Utility Values Using Direct and Response Mapping Methods

    Nov 1, 2013, 00:00

  • The Relationship Between Scientific Research, Clinical Trials and FDA Drug Approval

    Nov 1, 2013, 00:00

  • RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)

    Nov 1, 2013, 00:00

  • Characteristics of Hospitalizations Due to an Episode of Relapse in Multiple Sclerosis Brazilian Patients- A Retrospective Administrative Claims Analysis Under the Public Payer Perspective

    Nov 1, 2013, 00:00

  • The Short-Term Impact of Particulate Matter Exposure on the Risk of Prescription of Cardiorespiratory Drugs in Italy

    Nov 1, 2013, 00:00

  • Overview of Coverage with Evidence Development in Sweden

    Nov 1, 2013, 00:00

  • Long-Term Outcomes of Chronic Hepatitis C in the Population of Newly Diagnosed Russian Patients

    Nov 1, 2013, 00:00

  • Economic Impact of Stroke Episode in Patients Previous Diagnosed with Atrial Fibrillation in Private Health System in Brazil

    Nov 1, 2013, 00:00

  • Utilization Patterns for Treatment with Strong Opioids for Chronic Back Pain in Germany

    Nov 1, 2013, 00:00

  • Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality- A European Overview

    Nov 1, 2013, 00:00

  • Continuos Renal Replacement Therapy Versus Intermittent Hemodialysis- Systematic Review on Patient-Oriented Outcomes

    Nov 1, 2013, 00:00

  • Doubling of Health Care Costs Among Asthma Patients with COPD Diagnosis and Its Associated Co-Morbidities in a Claims Database in the United States

    Nov 1, 2013, 00:00

  • Nutrieconomic Exploratory Assessment of a Daily Consumption of Plant Sterols-Enriched Dairy Products on Statin’s Initiation Delay- A Consumer Perspective Approach

    Nov 1, 2013, 00:00

  • Aflibercept in Neovascular (Wet) Age-Related Macular Degeneration- An Analysis of the Payer Decision Landscape

    Nov 1, 2013, 00:00

  • Comparison of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Atrial Fibrillation in Ireland Over 5 Years

    Nov 1, 2013, 00:00

  • Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Turkey- A Payor Perspective

    Nov 1, 2013, 00:00

  • Driving After Drinking- Hospitalization, Mortality Rate, and Costs Pre and Post Prohibition in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Are Israeli Adults Willing to Pay Higher Health Taxes for a Wider Coverage of Life-Extending Medications?

    Nov 1, 2013, 00:00

  • Does It Matter? Discounting and Its Role in Analysing the Cost-Effectiveness of Preventative Interventions

    Nov 1, 2013, 00:00

  • Cost Analysis of the Use of an Operating Room with Full-Rotation 3-D Intraoperative Imaging and Navigation in Different Spine Surgeries

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Pruebas Para La Tamización De Bacteriuria Asintomática Durante La Gestación

    Nov 1, 2013, 00:00

  • Budget Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

    Nov 1, 2013, 00:00

  • Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes- A Matched Cohort Design

    Nov 1, 2013, 00:00

  • Economic Evaluation of Universal Antenatal HIV Screening Compared with Current “At Risk” Policy in Israel

    Nov 1, 2013, 00:00

  • Comparison of the Prices Used in the Manufacturers’ Budget Impact Analyses and the Prices from Reimbursed Drugs List

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United Kingdom

    Nov 1, 2013, 00:00

  • The Adoption of Health Technologies- A Survey of Brazilian Policy Makers

    Nov 1, 2013, 00:00

  • Comparative Efficiency Research- Meta-Analysis of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands- Retrospective Analysis of Health Insurance Data

    Nov 1, 2013, 00:00

  • Costs Associated with Cold Chain Used to Store and Transport Thermally Unstable Antiretroviral Drugs

    Nov 1, 2013, 00:00

  • Statin Cost-Effectiveness in Patients with Previous Coronary Heart Disease- A Systematic Review of the Cost-Effectiveness Analysis Derived from Single Randomised Clinical Trials

    Nov 1, 2013, 00:00

  • Baseline Characteristics, Weight and Glycaemic Change Among Patients in the United Kingdom with Type 2 Diabetes Mellitus (T2DM) Prescribed a New Antidiabetic Treatment Class in a Real World Setting

    Nov 1, 2013, 00:00

  • Compliance with Preventive Recommendations in Primary Care and Rate of Potentially Avoided Hospitalizations by Diabetes, Chronic Heart Failure or Chronic Pulmonary Obstructive Disease

    Nov 1, 2013, 00:00

  • Identification and Qualitative Assessment of Real World Data Sources- Example of Lymphoma and Multiple Myeloma in Europe

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Statins for Primary Prevention in Newly Diagnosed Type 2 Diabetes Patients in the Netherlands

    Nov 1, 2013, 00:00

  • The Importance of Safety Aspects in the Amnog Process in Germany- Is the G-Ba Assessment Consistent with That of the CHMP?

    Nov 1, 2013, 00:00

  • Economic Impact Model of Lipegfilgastrim to Prevent Neutropenia in Cancer Patients in Spain

    Nov 1, 2013, 00:00

  • Utility and Resource Use of an Australian Population of Psoriasis Patients

    Nov 1, 2013, 00:00

  • Recent Trends in Hospital Costs, Length of Stay, and Mortality Associated with Pediatric Meningococcal Disease in the United States

    Nov 1, 2013, 00:00

  • Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice Data

    Nov 1, 2013, 00:00

  • Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation Times

    Nov 1, 2013, 00:00

  • It Application for Post Marketing Drug Registries

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário Do Oclusor Septal Percutâneo Para O Fechamento De Comunicação Interatrial (CIA) Do Tipo Ostium Secundum

    Nov 1, 2013, 00:00

  • Usefulness of the Hypoglycemia Perspectives Questionnaire (HPQ) in Management of Patients with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Protective Factors for University Students’ Health

    Nov 1, 2013, 00:00

  • Economic Activity of Cancer Survivors in Poland

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Apomorphine in the Treatment of Advanced Parkinson Disease in the UK and Germany- Results from a Multicounty Decision Analytic Model

    Nov 1, 2013, 00:00

  • ¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios Científicos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?

    Nov 1, 2013, 00:00

  • Bis Sensor Versus Conventional Anesthetic Monitoring- Systematic Review on Patient-Oriented Outcomes

    Nov 1, 2013, 00:00

  • Approaches for Estimating Burden of Pneumococcal and Rotavirus Diseases- Conceptual Framework and Systematic Review

    Nov 1, 2013, 00:00

  • The Review of Publications of Pharmacoeconomic Research in Russia During 2007-2012

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol- 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • International Normalized Ratio (INR) Monitoring and Percent Time in Therapeutic INR Range (TTR) Have Impact on Patient’s Quality of Life? Application of Beta Regressions in a Prospective 3 Months Setting

    Nov 1, 2013, 00:00

  • Assessing Product Safety via Patient Based Active Surveillance (AS)- A Study in 30.000 Women Using Hormone Replacement Therapy (HRT)

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas Conjugadas 10 Y 13 Valente Para Niños En Antioquía, Colombia

    Nov 1, 2013, 00:00

  • Podcasts as a Learning Tool in a Research Methods Course for Pharmacy Students

    Nov 1, 2013, 00:00

  • Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer- An Italian Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Multi-state Statistical Modelling to Quantify an Individual-based Micro Simulation Model for Radiotherapy Treatment in Lung Cancer Patients

    Nov 1, 2013, 00:00

  • Time Savings with Once-Monthly C.E.R.A.- A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy

    Nov 1, 2013, 00:00

  • Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)

    Nov 1, 2013, 00:00

  • Evolución Del Consumo Y Ventas De Antibióticos En Chile 1998-2012

    Nov 1, 2013, 00:00

  • Crossover Adjustment in Oncology Trials Using a Rank Preserving Structural Failure Time Model (RPSFTM)- Wrapping Bootstraps Around Estimates of Life Expectancy for CE Models

    Nov 1, 2013, 00:00

  • Health Technology Assessment- Is It the Right Piece for the Jordanian Health Care Puzzle?

    Nov 1, 2013, 00:00

  • Treatment Patterns of Atrial Fibrillation (AF) in Latin America

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Health-Related Quality of Life Using EQ-5D

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France

    Nov 1, 2013, 00:00

  • Attitude of Parents Towards Obligatory and Recommended Childhood Vaccination

    Nov 1, 2013, 00:00

  • Can Administrative Data Predict Chemotherapy Adverse Events?

    Nov 1, 2013, 00:00

  • Assessment of Patient Population with NSCLC by Stage, ECOG-PS, EGFR Mutation Status and Line of Therapy in Germany

    Nov 1, 2013, 00:00

  • Incretin Therapy for Patients with Type 2 Diabetes in Spain- A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes Asssesment of Thai Chronic Stable Angina Pectoris(CSAP)

    Nov 1, 2013, 00:00

  • The Sustainability of Irish Pharmaceutical Expenditure

    Nov 1, 2013, 00:00

  • Introduction of Innovations into the German Statutatory Reimbrusment System – Factors for Success

    Nov 1, 2013, 00:00

  • Análisis De La Carga Financiera De Las Principales Enfermedades Reumatológicas

    Nov 1, 2013, 00:00

  • Clinical Outcome Assessments in FDA Oncology Labels Since 2010

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Spain- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Introduction of an Infliximab Biosimilar (CT-P13)- A Five-Year Budget Impact Analysis for the Treatment of Rheumatoid Arthritis in Ireland

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Capsule Endoscopy in Screening for Colorectal Cancer in Japan

    Nov 1, 2013, 00:00

  • Adding a Reminder Short Message Service (SMS) Before and Tablet Computer During Clinic Improves Electronic Patient Reported Outcome Measures (ePROMS) Collection

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in Brazil

    Nov 1, 2013, 00:00

  • Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH)- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • How Well Do We Understand the Economic Burden Associated with Dementia? A Focus on Trends in Care Home Costs and Future Perspectives in the United Kingdom

    Nov 1, 2013, 00:00

  • Feasibility of a Survey on the Willingness-To-Pay for Colorectal Cancer Screening Using Social Networks

    Nov 1, 2013, 00:00

  • External Validation of the Syreon Diabetes Model

    Nov 1, 2013, 00:00

  • Quality of Care for Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and Comparisons

    Nov 1, 2013, 00:00

  • Monitoring Health Processes in the Real World- An Italian Population Database Experience

    Nov 1, 2013, 00:00

  • Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors- The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

    Nov 1, 2013, 00:00

  • Frequency of Lower Urinary Tract Symptoms in Men and Women in Hungary – Results of an Open Label Questionnaire Study from 2012

    Nov 1, 2013, 00:00

  • Differences in Health Care Resource Utilization and Expenditures Among Schizophrenic Patients in the United States by Health Insurance Status, 2007-2008

    Nov 1, 2013, 00:00

  • The Impact of Increasing Pain Severity on Impairment of Regular Daily Activities

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine in Chronic Heart Failure in Greece

    Nov 1, 2013, 00:00

  • Public Health Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • Methodological Approaches for Modeling Cardiovascular Events in Cost-Effectiveness Analyses Based on Outcome Trials

    Nov 1, 2013, 00:00

  • Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient Populations

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paricalcitol in End Stage Chronic Kidney Disease Secondary Hyperparathyroidism Patients on Dialysis, in Brazil

    Nov 1, 2013, 00:00

  • Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Para El Manejo Farmacológico De La Hemofilia a Severa En 5 Entidades De Aseguramiento En Colombia

    Nov 1, 2013, 00:00

  • A Flexible Multi-State Modelling Framework for the Simulation of Cancer Progression and Cancer Care

    Nov 1, 2013, 00:00

  • Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies

    Nov 1, 2013, 00:00

  • Barriers Underlying Limited Utilisation of Vaccines Throughout Life (Lifespan Immunisation)

    Nov 1, 2013, 00:00

  • Scandinavian Drug Reimbursement and Coverage Decisions- The Role of HTA

    Nov 1, 2013, 00:00

  • Development of Novel Imaging Tests to Select Patients for Individualized Therapies- Are They Worth Further Investment?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Various Combinations of Human Papillomavirus (HPV)-Based Primary Screening Testing, Including Genotyping for HPV 16/18, for Cervical Cancer Screening in Mexico

    Nov 1, 2013, 00:00

  • Real Life Effects of Liraglutide Supports Those Shown in RCTs

    Nov 1, 2013, 00:00

  • Mobile Phone Use in Patient Reported Outcomes – A Literature Search

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the Polish Version of “Disabilities of the Arm, Shoulder and Hand” (DASH) and Quickdash Questionnaires

    Nov 1, 2013, 00:00

  • Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South India

    Nov 1, 2013, 00:00

  • Costos Asociados a Eventos Cardiovasculares En Pacientes Con Artritis Reumatoide Afiliados Al Régimen Subsidiado En Colombia

    Nov 1, 2013, 00:00

  • Graphic Health Warnings on Cigarette Packs in Qatar- Pre-Implementation Awareness and Perception Among the General Public

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine for Chronic Heart Failure NYHA II to IV Class with Systolic Dysfunction in Ireland

    Nov 1, 2013, 00:00

  • A Bayesian Dynamic Model of Asthma in the Real Life

    Nov 1, 2013, 00:00

  • A Systems-Thinking Approach for the Health Care Industry- Strategies and Insights for Biopharma, Payers and Providers

    Nov 1, 2013, 00:00

  • The Cost of Clostridium Difficile Infection in Hungary

    Nov 1, 2013, 00:00

  • Evaluating the Cost Effectiveness of Gene Expression Profiling and Immunohistochemistry Tests

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Medication Adherence Enhancing Interventions- A Systematic Review

    Nov 1, 2013, 00:00

  • Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec

    Nov 1, 2013, 00:00

  • Cost Analysis for Patients Hospitalised for Heart Failure in Germany

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom

    Nov 1, 2013, 00:00

  • Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Developing Personalized Medicine Drugs - Incentives for Pharmaceutical Companies

    Nov 1, 2013, 00:00

  • Different Injection Frequencies of Basal Insulins in Type 2 Diabetes Patients Under Real-Life Conditions- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Does Europe Reward Reformulations? A Data Driven Analysis of Value Preservation Through Reformulation

    Nov 1, 2013, 00:00

  • Pricing and Reimbursement System of Orphan Drugs in the Czech Republic

    Nov 1, 2013, 00:00

  • Effectiveness of Montelukast on Asthma Control in Infants- Methodology of a Claims Data Study

    Nov 1, 2013, 00:00

  • Paediatric Gastroenteritis- Disease Burden, Cost and Loss of Productivity of Malaysian and Vietnamese Parents

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

    Nov 1, 2013, 00:00

  • Patients Preferences for Long-Term Treatment After Acute Coronary Syndrome- A Discrete-Choice Experiment and Analytic Hierarchy Process

    Nov 1, 2013, 00:00

  • Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study

    Nov 1, 2013, 00:00

  • Further Validation of a New Questionnaire to Measure Satisfaction with Medical Care in Patients with Atrial Fibrillation (SAFUCA) in Spain

    Nov 1, 2013, 00:00

  • Costs of COPD in Fran A National Database Analysis

    Nov 1, 2013, 00:00

  • Estimating Market Potential for Biosimilar Introduction

    Nov 1, 2013, 00:00

  • The E-Health Impact Questionnaire- Developing a Tool to Measure the Effects of Using Health-Related Websites

    Nov 1, 2013, 00:00

  • Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence Levels

    Nov 1, 2013, 00:00

  • Budget Impact of Paliperidone Palmitate in Austria

    Nov 1, 2013, 00:00

  • Preliminary Testing of the Sagit Tool- A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice

    Nov 1, 2013, 00:00

  • Economic Burden of Patients with Painful Diabetic Neuropathy in Europe- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Evaluating Fatigue in Fibromyalgia- Development and Validation of the Daily Diary of Fatigue Symptoms in Fibromyalgia (DFS-Fibro)

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Hip and Thigh Injuries in Hungary in 2009

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin

    Nov 1, 2013, 00:00

  • Disposición a Pagar Y Análisis De Conjoint Para Determinar Las Preferencias Por Los Productos Medley En México

    Nov 1, 2013, 00:00

  • Using an Excel Calculator to Estimate Ankylosing Spondylitis Costs in Turkey

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine-Rituximab in First-Line Indolent NHL- A Patient-Level Simulation

    Nov 1, 2013, 00:00

  • Impact of Comorbidity Burden on Real-World Health Care Costs of Rheumatoid Arthritis Patients in Turkey

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Diagnostico Etiológico Con Pruebas Rapidas Vs. Sindromico En Mujeres No Gestantes Con Sintomas De Infección Cervical En Colombia

    Nov 1, 2013, 00:00

  • Analysis of the IQWIG Comments on the Evidence Searches of Dossiers in the German Amnog Process

    Nov 1, 2013, 00:00

  • Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom- Results from a General Practice Population Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Current Standard of Care in the Management of Type 1 and Type 2 Diabetes Mellitus in the Spanish Health System

    Nov 1, 2013, 00:00

  • Cost Reduction Associated with Use of Subglottic Aspiration to Reduce Ventilator-Associated Pneumonia in Turkey

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ipilimumab for the Treatment of Advanced Melanoma in the Veneto Region, Italy

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Chronic Pain Management in Russian Cancer Patients

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Skin and Soft Tissue Infection in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

    Nov 1, 2013, 00:00

  • Re-Establishing the Societal Value of Pediatric Combination Vaccines

    Nov 1, 2013, 00:00

  • Microsimulation or Cohort Modelling? A Case Study in Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • A Unified Methodological Framework for the Economic Evaluation of Therapeutic Medical Devices

    Nov 1, 2013, 00:00

  • Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching Hospital

    Nov 1, 2013, 00:00

  • Etanercept 25 Mg Once Weekly Could Be a Cost-Effective Option for Rheumatology Patients in Sustained Clinical Remission

    Nov 1, 2013, 00:00

  • Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care Setting

    Nov 1, 2013, 00:00

  • Treatment and Outcome Analysis of Rodenticide Poisoning in Tertiary Care Hospital in South India

    Nov 1, 2013, 00:00

  • Health Insurance Cost of Epilepsy in Hungary- A Cost of Illness Study

    Nov 1, 2013, 00:00

  • Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain” Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative Methods

    Nov 1, 2013, 00:00

  • Disease Status, Treatments and Outcomes of Patients with Ankylosing Spondylitis Receiving Their First Biologic in the United States and European Union

    Nov 1, 2013, 00:00

  • Comparative Responsiveness of Direct and Mapped SF-6D Preference-Based Measures in Colorectal Cancer

    Nov 1, 2013, 00:00

  • Estimation of Generic Utilities in Spanish Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2013, 00:00

  • Evaluate the Status of Pharmacoeconomic Research Development in China from 2002 to 2013

    Nov 1, 2013, 00:00

  • Economic Consequences of Nonalcoholic Steatohepatitis in the United States

    Nov 1, 2013, 00:00

  • La Utilidad Predictiva Del Euroscore Puede Ser Mejorada Al Adicionar Valores De Peptido Natriurético Tipo B O De Hemoglobina

    Nov 1, 2013, 00:00

  • Retrospective Costing Study to Estimate Burden of Heart Failure in Spain

    Nov 1, 2013, 00:00

  • Pricing and Reimbursment of Pharmaceuticals in Iran

    Nov 1, 2013, 00:00

  • Treatment Adherence and Costs in Multiple Sclerosis- A Narrative Review of the Literature

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sugammadex for Routine Reversal of Neuromuscular Blockade, with Extubation at a TOF Ratio of 0.9, in Anaesthetised Patients Undergoing Elective Surgery in England and Wales

    Nov 1, 2013, 00:00

  • Mothers’ Own Milk for the Feeding of Preterm Infants- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) During Treatment of Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • Derivation of Severity Index for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure- Application in Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Direct and Indirect Costs of MS in Ireland

    Nov 1, 2013, 00:00

  • Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in Mexico

    Nov 1, 2013, 00:00

  • Modeling the Impact of Disease Modifying Treatment on Time to Disability Health States in Multiple Sclerosis- An Evaluation of Oral Therapies Through Indirect Comparisons of 6-Month Confirmed Disability Progression

    Nov 1, 2013, 00:00

  • Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases- Health Professionals’ View in Serbia

    Nov 1, 2013, 00:00

  • Evaluation of Associations Among Biomarkers, Correlates and Treatment Efficacy in Clinical Studies in Patients Diagnosed with Non-Psychotic Major Depressive Disorder- A Literature Review

    Nov 1, 2013, 00:00

  • Regulating the Access to an Adequate and an Integral Assistance in Brazilian Private Health Plans

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting

    Nov 1, 2013, 00:00

  • Health Technology Assessment of High-Value Therapies

    Nov 1, 2013, 00:00

  • Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China

    Nov 1, 2013, 00:00

  • Testing the Eunethta Internal Validity of Randomized Controlled Trials Guideline and Tool in Hungary

    Nov 1, 2013, 00:00

  • Cost Analysis of an Intensive Care Unit

    Nov 1, 2013, 00:00

  • Trends in the Cost-Effectiveness of Stroke Care

    Nov 1, 2013, 00:00

  • Dual Back Translation Versus Single Back-Translation Methodology When Translating Patient Reported Outcomes (PRO)

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil

    Nov 1, 2013, 00:00

  • Variability of Clinical Practice for Bariatric Surgery in Spain

    Nov 1, 2013, 00:00

  • Using Multi-Criteria Decision Analysis to Support Allocation Decisions in Large Translational Research Projects

    Nov 1, 2013, 00:00

  • Comparative Analysis of the Cost and Metabolic Control in Diabetic Children Using Insulin Pumps

    Nov 1, 2013, 00:00

  • The Ecology of Medical Care in Poor Settings- Self Reported Health Care Utilization in Santiago Del Estero, Argentina

    Nov 1, 2013, 00:00

  • Impacto Do Uso Do Microdebridador Nos Desfechos E Custos Nas Cirurgias Endoscópicas Nasais

    Nov 1, 2013, 00:00

  • The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy

    Nov 1, 2013, 00:00

  • Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in Japan

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Contrast-Enhanced Ultrasound (CEUS) Techniques

    Nov 1, 2013, 00:00

  • COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

    Nov 1, 2013, 00:00

  • Socio-Economic Impact of Alzheimer’s Disease in Gree Pilot Study

    Nov 1, 2013, 00:00

  • Bayesian Analysis of Malformation Outcome in Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy- An Indirect Comparison of Citalopram, Fluoxetine, Paroxetine, and Sertraline

    Nov 1, 2013, 00:00

  • The Impact of the Blind Bid Procedure in Hungary

    Nov 1, 2013, 00:00

  • Development of an Interviewer-Administered Version of the Asthma Control Questionnaire (ACQ-IA) for 6-10 Year Old Patients in 11 Languages

    Nov 1, 2013, 00:00

  • Validation of Accept, a New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-life

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Diagnostic Tests in the Work-Up of Patients with Intermediate Risk of Developing Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • How Does the Uncertainty Around the Expected ICER Affect Nice Decisions?

    Nov 1, 2013, 00:00

  • Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation- A Community Study

    Nov 1, 2013, 00:00

  • A Literature Review on the Humanistic and Economic Burden of Mineralocorticoid Excess Syndrome

    Nov 1, 2013, 00:00

  • Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Clinical and Cost-effectiveness of a Procalcitonin Test as a Prompt Indicator of Prodomol Meningococcal Disease in Febrile Children- Cost-effectiveness Analysis

    Nov 1, 2013, 00:00

  • Cost Analysis of a Fibrin Sealant Patch for Mild, Moderate and Problematic Soft Tissue Surgical Bleeding- A Hospital Perspective

    Nov 1, 2013, 00:00

  • Cost of Inpatient Management of Hypoglycaemia in France

    Nov 1, 2013, 00:00

  • Cost-minimization Analysis of Dienogest Versus Gonadotrophin-releasing Hormone Analogues or Dydrogesterone for Endometriosis Treatment in Russia

    Nov 1, 2013, 00:00

  • The Impact of Daytime and Nocturnal Non-Severe Hypoglycaemic Events on People with Diabetes in Brazil

    Nov 1, 2013, 00:00

  • ISPOR 16th Annual European Congress Author Index

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Oncology Drugs

    Nov 1, 2013, 00:00

  • Análisis Del Impacto En La Demanda De Tecnologías Incluidas En El Plan De Beneficios Colombiano (POS) Posterior A Su Actualización En 2012

    Nov 1, 2013, 00:00

  • An Approach for Quantification of Patient Advocacy Group Input in the HTA Process

    Nov 1, 2013, 00:00

  • Considering Economic Analyses in the Revision of the Preventive Vaccination Law- A New Direction for Health Policy-Making in Japan?

    Nov 1, 2013, 00:00

  • Novel Oral Anticoagulants Versus Warfarin – A Business Case Analysis

    Nov 1, 2013, 00:00

  • Applicability of Japanese Health Care Database to Clinical Trial Planning for Dyslipidaemia Drug

    Nov 1, 2013, 00:00

  • Preference Structure of Clinicians in the Use of Electronic Medical Records; Quantifying the Relative Importance of Barriers and Facilitators of an Innovation

    Nov 1, 2013, 00:00

  • The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium

    Nov 1, 2013, 00:00

  • Catching the Low-Hanging Fruit in Medicines Optimisation

    Nov 1, 2013, 00:00

  • Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes

    Nov 1, 2013, 00:00

  • UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONS

    Nov 1, 2013, 00:00

  • The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium

    Nov 1, 2013, 00:00

  • Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC)- A Systematic Review and Indirect Comparison of Safety and Efficacy

    Nov 1, 2013, 00:00

  • Cost Analysis of Alprostadil (Prostavasin®) as Treatment for Patients with Peripheral Arterial Disease Stages III and IV Compared with Lumbar Sympathectomy in Mexico

    Nov 1, 2013, 00:00

  • Efecto De La Determinación De La Concentración Capilar De Proteína C Reactiva En La Tasa De Prescripción De Antibióticos Para El Tratamiento De Infección De Vías Respiratorias Altas (Análisis De Costo-Efectividad)

    Nov 1, 2013, 00:00

  • Nice STA Decisions- An Analysis of How Advice Differs Between Preliminary and Final Guidance

    Nov 1, 2013, 00:00

  • A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

    Nov 1, 2013, 00:00

  • Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and Spain

    Nov 1, 2013, 00:00

  • Etanercept Provides Improved Quality of Life Regardless of the Presence of Psoriatric Arthritis in Moderate/Severe Psoriasis Subjects from Central and Eastern Europe, Latin America and Asia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia

    Nov 1, 2013, 00:00

  • Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada- A Questionnaire-Based Study

    Nov 1, 2013, 00:00

  • Health Economic Modelling of Sequential Therapies for Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2013, 00:00

  • Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States

    Nov 1, 2013, 00:00

  • Can the Use of Social Media and Mobile Apps Improve Patient Knowledge of Disease and Health Outcomes? A Systematic Review

    Nov 1, 2013, 00:00

  • Survival Analysis Used in Company Submissions to the National Centre for Pharmacoeconomics, Ireland

    Nov 1, 2013, 00:00

  • Transparency of the Medicines Reimbursement System in Ireland- A Quantative Analysis of the Influences on Reimbursement Decisions [2006-2013]

    Nov 1, 2013, 00:00

  • Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

    Nov 1, 2013, 00:00

  • The Transparency of National Health Care Costs in the ‘European Union Five (EU-5)’

    Nov 1, 2013, 00:00

  • Quality of Life Benefits and Cost Impact of Prolonged Release Oxycodone/Naloxone Versus Prolonged Release Oxycodone in Patients with Moderate to Severe Pain and Opioid-Induced Constipation Despite the Use of 2 Laxatives- A UK Cost Utility A ...

    Nov 1, 2013, 00:00

  • Analysis Cost Effectiveness of Pharmacological Prophylaxis of Contrast-Induced Nephropathy

    Nov 1, 2013, 00:00

  • The List of Medicines for COPD Treatment in State Formulary of Ukraine and Related Costs

    Nov 1, 2013, 00:00

  • Patients as a Source for Cost of Rheumatoid Arthritis Study

    Nov 1, 2013, 00:00

  • A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin America

    Nov 1, 2013, 00:00

  • Costs and Consequences of Oral Anticoagulation in Atrial Fibrillation in Colombia

    Nov 1, 2013, 00:00

  • Health-State Utilities in Measuring Health-Related Quality of Life Among Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Abatacept for Treatment of Adults with Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Clinical Significance of Change in the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Score in Adult Growth Hormone Deficiency (AGHD)

    Nov 1, 2013, 00:00

  • Model-Based Economic Evaluations in Alzheimer’s Disease - A Review of Modeling Methods

    Nov 1, 2013, 00:00

  • Pharmaco-Economic Education Needs Investigated by ISPOR Chapter – Example from Bulgaria

    Nov 1, 2013, 00:00

  • Is It Worth Having Orphan Drug Status in Germany Post-Amnog?

    Nov 1, 2013, 00:00

  • Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con Cineangiocoronariografías Realizadas En Uruguay Financiadas Por El Fondo Nacional De Recursos

    Nov 1, 2013, 00:00

  • Impacto Económico Y En Discapacidad Del Incrementro De Utilización De Trombolisis En El Cuidado Agudo De L Ictus Isquémico En Chile

    Nov 1, 2013, 00:00

  • Proposal of Economic Evaluation Guideline in Japan

    Nov 1, 2013, 00:00

  • Evolución En El Uruguay De Tazas De Utilización De Cateterismo Cardíaco Diagnostico Par a Cardiopatía Congénita En Menores De 18 Años (1995-2012)

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Dos Formulaciones De Toxina Botulínica Tipo a (TBA) En Colombia Para El Tratamiento De La Parálisis Cerebral Infantil (PCI)

    Nov 1, 2013, 00:00

  • Disentangling Effects on Fatal and Non-Fatal Cardiovascular Events Over Time

    Nov 1, 2013, 00:00

  • Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2013, 00:00

  • A Systematic Review of the Effectiveness of Taxes in Preventing Obesity Trends

    Nov 1, 2013, 00:00

  • Cost Effectiveness Evaluation of a Rotavirus Vaccination Program in Argentina

    Nov 1, 2013, 00:00

  • Assessing Non-Inferiority of Aclidinium Bromide 400 mG Bid Versus Tiotropium 18 mG and 5 mG Qd in Patients with Chronic Obstructive Pulmonary Disease (COPD) by Means of a Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Health Related Quality of Life by Line of Therapy in Imatinib-Resistant or Imatinib-Intolerant Patients with Chronic Myeloid Leukemia Treated with Bosutinib Measured by EQ-5D

    Nov 1, 2013, 00:00

  • Estimating the Cardiovascular Benefits of DPP-4 Inhibitors- A Simulated Study

    Nov 1, 2013, 00:00

  • Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast Cancer

    Nov 1, 2013, 00:00

  • Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections- A Budget Impact Analysis in the Greek Hospital Setting

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic in Europe Union and the United States

    Nov 1, 2013, 00:00

  • Long-Term Outcomes of Sofosbuvir (SOF) for the Treatment of Chronic Hepatitis C Infected (CHC) Patients

    Nov 1, 2013, 00:00

  • Medical Costs of Patients with Rheumatoid Arthritis and Association with Global Disease Activity in Turkey

    Nov 1, 2013, 00:00

  • A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

    Nov 1, 2013, 00:00

  • A Comparative Study of the Role of Disease Severity in Drug Reimbursement Decision Making in Belgium, France, the Netherlands and Sweden

    Nov 1, 2013, 00:00

  • Qualidade De Vida Em Pacientestransplantados Renais

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Predicting the Frequency of Severe and Non-Severe Hypoglycaemia in Insulin Treated Type-2 Diabetes Subjects

    Nov 1, 2013, 00:00

  • Estimation of the Cost-Effectiveness of Apixaban in Non-Valvular Atrial Fibrillation in Argentina

    Nov 1, 2013, 00:00

  • Burden of Disease of Cervical Dystonia in the United Kingdom

    Nov 1, 2013, 00:00

  • The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment

    Nov 1, 2013, 00:00

  • Resource Use and Cost of Diagnosis and Management of Breast Cancer by Stage in an Irish Teaching Hospital

    Nov 1, 2013, 00:00

  • Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQ”

    Nov 1, 2013, 00:00

  • Association Between Non-Motor Symptoms and Health Care Utilization Among Patients with Parkinson’s Disease in the United States

    Nov 1, 2013, 00:00

  • Cost-Outcome Description of Clinical Pharmacist Interventions in a University Teaching Hospital

    Nov 1, 2013, 00:00

  • Application of Health Technology Assessment and Pharmacoeconomics in the Decision-Making Process in Selected Eu Member States

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Everolimus in the Treatment of Metastatic Renal Cell Cancer in the Netherlands

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the SF-6D Questionnaire for Use in Arabic-Speaking Countries

    Nov 1, 2013, 00:00

  • Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Weight Loss of ≥3% in Type II Diabetes Patients Is Associated with Weight Change Property of Newly Prescribed Anti-Diabetic Medicine in Anti-Depressant Users Over a 12-Month Follow-Up Period

    Nov 1, 2013, 00:00

  • Hypercholesterolemia’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in the Children and Adolescents

    Nov 1, 2013, 00:00

  • Health Care Resources Utilization in Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Economic Burden of Axial Spondyloarthritis Related to Paid Work and Household Productivity at Baseline in the Rapid-axSpA Study- Differences and Similarities Between Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2013, 00:00

  • Collaborative Care for Depression Management in Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Sitagliptin in Diabetes Mellitus Treatment in China

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

    Nov 1, 2013, 00:00

  • Health Care Costs of HIV in the Czech Republic. A Single Center Analysis

    Nov 1, 2013, 00:00

  • Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia

    Nov 1, 2013, 00:00

  • Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders

    Nov 1, 2013, 00:00

  • Budget Impact Analysis for the Use of Vandetanib in Mexican Adult Patient Diagnosed with Advanced Unresectable Medullary Thyroid Cancer

    Nov 1, 2013, 00:00

  • Unmet Needs and Biologic Use Among Patients with Rheumatoid Arthritis in Brazil

    Nov 1, 2013, 00:00

  • Assessment of Cost-Effectiveness Models for Biologics in the Management of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Health Care Cost of Type 2 Diabetes Patients in Gree Sub-Population Analysis

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Comparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Fatigue Using Modified Fatigue Impact Scale

    Nov 1, 2013, 00:00

  • Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

    Nov 1, 2013, 00:00

  • Assessment of Burden of Illness Due to Herpes Zoster in Argentina- A Prospective Observational Study

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário- Quanto Custaria Ao Sistema Público De Saúde Brasileiro Incrementar, Por Meio De Transplantes, O Tratamento Da Doença Renal Crônica Terminal?

    Nov 1, 2013, 00:00

  • La Protección Financiera Y El Gasto De Bolsillo En Salud De La Población Mexicana 2002-2010

    Nov 1, 2013, 00:00

  • Economic Impact of Including Sequential Bevacizumab for the Treatment of Patients with Kirsten Ras Wild Type Unresectable Metastatic Colorectal Cancer in Four Latin American Countries

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of an Interface Geriatric Intervention- Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)

    Nov 1, 2013, 00:00

  • Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data

    Nov 1, 2013, 00:00

  • Can a Multi-Criteria Decision (MCD) Optimisation Model Help Decision Makers in the Optimal Selection of Vaccines When Expanding Their Universal Mass Vaccination Programme? The Case of Poland

    Nov 1, 2013, 00:00

  • Pregnancy After Breast Cancer in 2000-2002 and 2010-2012- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Comparing Health-Related Quality of Life Across Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis- Analyses from Certolizumab Pegol Clinical Trial Baseline Data

    Nov 1, 2013, 00:00

  • Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos Normais

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis (CMA) of Different Strategies to Treat Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Lost in Translation- Translatability of Psychiatric Terms – The Example of the Mini–International Neuropsychiatric Interview (M.I.N.I.)

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer in Kazakhstan

    Nov 1, 2013, 00:00

  • Análisis Comparativo De Insulina Glargina Frente a Insulina Detemir- Modelo De Minimización De Costos Para Colombia

    Nov 1, 2013, 00:00

  • Comparison Retail Prices of Drug Prices Between Turkey and European Countries

    Nov 1, 2013, 00:00

  • Defining Standards of Clinician Qualifications for the Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112 (current)
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »